Exendin for treating diabetes and reducing body weight

Details for Australian Patent Application No. 2006283517 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Fineman, Mark; MacConell, Leigh; Taylor, Kristin

Agent Spruson & Ferguson

Pub. Number AU-B-2006283517

PCT Pub. Number WO2007/024700

Priority 60/779,216 03.03.06 US; 60/709,604 19.08.05 US

Filing date 18 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 2 December 2010

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/024700 Priority application(s): WO2007/024700

2 December 2010 Application Accepted

  Published as AU-B-2006283517

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283518-Microfluidic methods for diagnostics and cellular analysis

2006283516-Flexible protective coating